828
Views
24
CrossRef citations to date
0
Altmetric
Reviews

Can targeting SIRT-1 to treat type 2 diabetes be a good strategy? A review

, MSc, , MS Pharm, , MPharm, , PhD & , PhD
Pages 819-832 | Published online: 05 Jul 2012

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.